SEC61A1 and Miyoshi myopathy: Having shown that Sec61 blockade by mycolactone elicits potent ER stress responses (Morel et al, 2018), we selected the MM cancer model for proof‐of‐concept because of its particularly high susceptibility to proteotoxic stress (Vincenz et al, 2013).